[Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
D000328:Adult; D000368:Aged; D000920:Antibody-Dependent Cell Cytotoxicity; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000627:therapeutic use*; D014565:Urogenital Neoplasms / Q000276:immunology* / Q000628:therapy
D001688:Biological Products; D010844:Picibanil